Endogenous nitrogen-scavenging conjugation pathways

Endogenous nitrogen-scavenging conjugation pathways are metabolic routes that facilitate the excretion of nitrogen independently of the urea cycle. In patients with urea cycle disorders (UCDs), these pathways are therapeutically activated using nitrogen-scavenging agents like sodium benzoate or phenylbutyrate (Summar et al., 2013, PubMed). Sodium benzoate conjugates with glycine to form hippurate, while phenylbutyrate is metabolized to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine; both products are then excreted by the kidneys (Lichter-Konecki et al., 2011, GeneReviews). By removing glutamine and glycine, these pathways effectively scavenge nitrogen that would otherwise contribute to toxic ammonia levels (Häberle et al., 2019, Orphanet Journal of Rare Diseases). These pathways are critical for preventing hyperammonemic crises and associated neurological damage in patients with enzymatic deficiencies in the urea cycle (Mokhtarani et al., 2012, Molecular Genetics and Metabolism). Pharmacological manipulation of these pathways requires careful monitoring of amino acid levels and renal function to ensure efficacy and safety (FDA, Ravicti Prescribing Information). These pathways represent a vital alternative for waste nitrogen disposal when the primary hepatic urea cycle is compromised.

Other names

Nitrogen scavenging pathwaysAlternative nitrogen excretion pathwaysAmmonia scavenging pathwaysAmino acid conjugation pathwaysAlternative waste nitrogen disposal pathways

Nitrogen-scavenging drugs provide an alternative route for nitrogen disposal by utilizing endogenous enzymes to conjugate organic acids with nitrogen-carrying amino acids like glutamine or glycine, resulting in water-soluble metabolites excreted in urine (Summar et al., 2013).